Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Ado-Trastuzumab Emtansine × Breast × Clear all

Status

Completed 41 Active not recruiting 13 Terminated 12 Recruiting 11 Unknown 8 Withdrawn 4 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

veliparib 2 tucatinib 1 pegilodecakin 1 palbociclib 1 leronlimab 1 iniparib 1 glembatumumab vedotin 1 Vinorelbine 1 Letrozole 1 Everolimus 1 Cisplatin 1 Alpelisib 1 Ado-Trastuzumab Emtansine 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01120561 2017-02-15

A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer

Genentech, Inc.

No longer available

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡